Positive top-line results have been announced from a confirmatory clinical study for AVT06, a biosimilar to Eylea (aflibercept) developed by the biotech Alvotech.
Adopting the ‘365 breathing technique’ helped reduce intraocular pressure (IOP) in primary openangle glaucoma patients, a new study has found.
Autonomous artificial intelligence (AI) systems for diagnosing diabetic eye disease (DED) have the potential to increase DED screening rates in underserved youth, while also
Australian company Eyerising International has rejected as “inaccurate” and “misleading”, an article by United States researchers about the safety of low-level redlight (LLRL) treatment
DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.
